Anthem Issues Positive Coverage Policy for Inspire Therapy
This positive coverage decision provides additional OSA patients who are unable to benefit from CPAP the opportunity to gain access to Inspire therapy.”
Read MoreAuthor: Sree Roy
The Fallacy of Full-Face CPAP Masks (Editor’s Message)
An ATS workshop report’s major conclusion was that nasal CPAP should be the initial mask option for most patients.
Read More
5-Year Study Confirms Safety, Efficacy, Beneficial Effects of Remedē System
The data show sustained improvements from baseline that were highly consistent with the previously published 6-, 12-, 24-, and 36-month results.
Read More
Sleep Apnea Pill Data Presented at ATS 2021: ‘These Data Reinforce the Potential of Pharmacotherapy in Treating OSA’
The administration of reboxetine plus oxybutynin before bedtime greatly decreased OSA severity and increased next-day vigilance after 1 week.
Read More
2 Sleep Companies Make The Startup Weekly’s ‘2021 Healthcare Companies to Watch’ List
The Startup Weekly has named 9 companies to its “2021 Healthcare Companies to Watch” list, including 2 sleep companies.
Read More